Correlation of PCSK1 with nonalcoholic fatty liver disease in a Han Chinese population: a case-control observational study

Correlation of PCSK1 with nonalcoholic fatty liver disease in a Han Chinese population: a case-control observational study

Objective:. This study aimed to investigate the association between single-nucleotide polymorphisms (SNPs) of PCSK1 (proprotein convertase subtilisin/kexin type 1) related to obesity and nonalcoholic fatty liver disease (NAFLD). Methods:. In this case-control observational study, four candidate SNPs...

Full description

Bibliographic Details
Main Authors:	Xiao Yang, Fan Yuan, Na Wu, Decheng Ren, Liangjie Liu, Yan Bi, Lei Ji, Ke Han, Mofan Feng, Kai Su, Fengping Yang, Xi Wu, Qing Lu, Siran Yue, Fengyan Jiang, Ruirui Wang, Guang He, Baocheng Liu, Xingwang Li, Yi Shi
Format:	Article
Language:	English
Published:	American Association for the Advancement of Science (AAAS) 2022-09-01
Series:	Journal of Bio-X Research
Online Access:	http://journals.lww.com/10.1097/JBR.0000000000000124

Similar Items

Erratum to: “Correlation of PCSK1 with Nonalcoholic Fatty Liver Disease in a Han Chinese Population: A Case-Control Observational Study”
by: Xiao Yang, et al.
Published: (2024-01-01)

Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
by: Na Wu, et al.
Published: (2021-11-01)

Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study
by: Jie Li, et al.
Published: (2023-01-01)

Upregulation of DGCR8, a Candidate Predisposing to Schizophrenia in Han Chinese, Contributes to Phenotypic Deficits and Neuronal Migration Delay
by: Yan Bi, et al.
Published: (2022-04-01)

The host genetics affects gut microbiome diversity in Chinese depressed patients
by: Ke Han, et al.
Published: (2023-01-01)

Fermented Rhus Verniciflua Stokes Extract Alleviates Nonalcoholic Fatty Liver through the AMPK/SREBP1/PCSK9 Pathway in HFD-Induced Nonalcoholic Fatty Liver Animal Model
by: Seon-Ok Lee, et al.
Published: (2020-09-01)

College students’ screening early warning factors in identification of suicide risk
by: Ke Han, et al.
Published: (2022-11-01)

Association of PCSK1 rs6234 with obesity and related traits in a Chinese Han population.
by: Qibin Qi, et al.
Published: (2010-05-01)

Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population
by: Gaojun Cai, et al.
Published: (2018-09-01)

Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol
by: George N. Ioannou, et al.
Published: (2022-04-01)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Lean nonalcoholic fatty liver disease and sarcopenia
by: Milian Chen, et al.
Published: (2023-06-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population
by: Wen Guo, et al.
Published: (2018-01-01)

Association of Monounsaturated Fatty Acid Intake with Nonalcoholic Fatty Liver Disease Risk in Chinese Han Adults: a Retrospective Case-control Study
by: FU Wei, CHENG Guobin, LYU Linya, DING Yao, WANG Yao, ZHAO Junlong
Published: (2024-10-01)

Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population
by: Yingyu Xu, et al.
Published: (2019-01-01)

The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
by: Lincheng Yang, et al.
Published: (2022-04-01)

Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease
by: Bing Yang, et al.
Published: (2022-01-01)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
by: Na Fei, et al.
Published: (2020-02-01)

Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
by: Mingzuo Jiang, et al.
Published: (2019-04-01)

Risk Factors for Nonalcoholic Fatty Liver Disease with Different Insulin Resistance in a Nonobese Chinese Population
by: Xiaojuan Wu, et al.
Published: (2022-01-01)

Association between SLC17A7 gene polymorphisms and venlafaxine for major depressive disorder in a Chinese Han population: a prospective pharmacogenetic case-control study
by: Liangjie Liu, et al.
Published: (2021-09-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
by: Guang Ji, et al.
Published: (2022-10-01)

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis
by: Na Wu, et al.
Published: (2024-01-01)

Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease
by: Boyuan Ma, et al.
Published: (2023-06-01)

Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01)

Nonalcoholic fatty liver disease
by: Sandra K. Erickson
Published: (2009-01-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β‐Oxidation
by: Danyu Wu, et al.
Published: (2020-01-01)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
by: Hye Ran Yang
Published: (2013-02-01)

Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China
by: Li-Zhen Chen, et al.
Published: (2019-02-01)

Role of extracellular vesicles in nonalcoholic fatty liver disease
by: Wei Jiang, et al.
Published: (2023-07-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease
by: Dingfeng Wu, et al.
Published: (2022-12-01)

Gut microbiota in obesity and nonalcoholic fatty liver disease
by: Lina Guo, et al.
Published: (2021-06-01)

Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Lishan Zhou, et al.
Published: (2018-01-01)

Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease
by: Ke Liu, et al.
Published: (2024-01-01)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
by: Hangkai Huang, et al.
Published: (2023-11-01)